Potent Pre-Clinical and Early Phase Clinical Activity of EP300/CBP Bromodomain Inhibitor CCS1477 in Multiple Myeloma

Blood(2022)

引用 1|浏览18
暂无评分
关键词
ep300/cbp bromodomain inhibitor ccs1477,multiple myeloma,pre-clinical
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要